Effect on body weight and composition in overweight/obese Australian adults over 12 months consumption of two different types of fibre supplementation in a randomized trial

Nutrition and Metabolism

Volumn 13, Issue 1, 2016, Pages 1-10

  Pal, Sebely ^a   Ho, Suleen ^a   Gahler, Roland J ^b   Wood, Simon ^a,b,c  

^a CURTIN UNIVERSITY   (Australia)

^b Factors Group Research   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Body composition; Fibre; Obesity; PGX; Psyllium

Indexed keywords

ISPAGULA; POLYSACCHARIDE; WATER;

ADULT; AGED; ARTICLE; AUSTRALIAN; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; DIARRHEA; DIET THERAPY; DIETARY FIBER; DOUBLE BLIND PROCEDURE; FEMALE; FLATULENCE; FLUID INTAKE; HUMAN; KINESIOTHERAPY; LEAN BODY WEIGHT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; OBESITY; OUTCOME ASSESSMENT; PARALLEL DESIGN; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT DURATION; WEIGHT REDUCTION;

EID: 84995532089     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/s12986-016-0141-7     Document Type: Article

References (44)

1. Marlett JA, McBurney MI, Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2002;102:993-1000.
2. National Health and Medical Research Council. Australian Dietary Guidelines. Canberra: National Health and Medical Research Council; 2013.
3. US Department of Agriculture US Department of Health and Human Services. Dietary Guidelines for Americans. Washington: US Government Printing Office; 2005.
4. Du H, DL V d A, Boshuizen HC, Forouhi NG, Wareham NJ, Halkjaer J, et al. Dietary fiber and subsequent changes in body weight and waist circumference in European men and women. Am J Clin Nutr. 2010;91:329-36.
5. Newby PK, Maras J, Bakun P, Muller D, Ferrucci L, Tucker KL. Intake of whole grains, refined grains, and cereal fiber measured with 7-d diet records and associations with risk factors for chronic disease. Am J Clin Nutr. 2007;86:1745-53.
6. Wu H, Dwyer KM, Fan Z, Shircore A, Fan J, Dwyer JH. Dietary fiber and progression of atherosclerosis: the Los Angeles Atherosclerosis Study. Am J Clin Nutr. 2003;78:1085-91.
7. Lairon D. Macronutrient intake and modulation on chylomicron production and clearance. Atheroscler Suppl. 2008;9:45-8.
8. Kan H, Stevens J, Heiss G, Klein R, Rose KM, London SJ. Dietary fiber intake and retinal vascular caliber in the atherosclerosis risk in communities study. Am J Clin Nutr. 2007;86:1626-32.
9. Lairon D, Arnault N, Bertrais S, Planells R, Clero E, Hercberg S, et al. Dietary fiber intake and risk factors for cardiovascular disease in French adults. Am J Clin Nutr. 2005;82:1185-94.
10. Venn BJ, Mann JI. Cereal grains, legumes and diabetes. Eur J Clin Nutr. 2004;58:1443-61.
11. Weickert MO, Pfeiffer AF. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr. 2008;138:439-42.
12. McKeown NM, Meigs JB, Liu S, Wilson PW, Jacques PF. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr. 2002;76:390-8.
13. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69:30-42.
14. Pittler MH, Ernst E. Guar gum for body weight reduction: meta-analysis of randomized trials. Am J Med. 2001;110:724-30.
15. Ludwig DS, Pereira MA, Kroenke CH, Hilner JE, Van Horn L, Slattery ML, et al. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA. 1999;282:1539-46.
16. Clemens R, Kranz S, Mobley AR, Nicklas TA, Raimondi MP, Rodriguez JC, et al. Filling America's fiber intake gap: summary of a roundtable to probe realistic solutions with a focus on grain-based foods. J Nutr. 2012;142:1390S-401S.
17. Jenkins AL, Kacinik V, Lyon M, Wolever TM. Effect of adding the novel fiber, PGX®, to commonly consumed foods on glycemic response, glycemic index and GRIP: a simple and effective strategy for reducing post prandial blood glucose levels - a randomized, controlled trial. Nutr J. 2010;9:58.
18. Reimer RA, Pelletier X, Carabin IG, Lyon M, Gahler R, Parnell JA, et al. Increased plasma PYY levels following supplementation with the functional fiber PolyGlycopleX in healthy adults. Eur J Clin Nutr. 2010;64:1186-91.
19. Blackwood AD, Salter J, Dettmar PW, Chaplin MF. Dietary fibre, physicochemical properties and their relationship to health. J R Soc Promot Health. 2000;120:242-7.
20. Pal S, Khossousi A, Binns C, Dhaliwal S, Ellis V. The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals. Br J Nutr. 2011;105:90-100.
21. Ziai SA, Larijani B, Akhoondzadeh S, Fakhrzadeh H, Dastpak A, Bandarian F, et al. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol. 2005;102:202-7.
22. Karhunen LJ, Juvonen KR, Flander SM, Liukkonen KH, Lahteenmaki L, Siloaho M, et al. A psyllium fiber-enriched meal strongly attenuates postprandial gastrointestinal peptide release in healthy young adults. J Nutr. 2010;140:737-44.
23. Anderson JW, Allgood LD, Lawrence A, Altringer LA, Jerdack GR, Hengehold DA, et al. Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr. 2000;71:472-9.
24. Rodriguez-Moran M, Guerrero-Romero F, Lazcano-Burciaga G. Lipid- and glucose-lowering efficacy of Plantago Psyllium in type II diabetes. J Diabetes Complications. 1998;12:273-8.
25. Vuksan V, Jenkins AL, Rogovik AL, Fairgrieve CD, Jovanovski E, Leiter LA. Viscosity rather than quantity of dietary fibre predicts cholesterol-lowering effect in healthy individuals. Br J Nutr. 2011;106:1349-52.
26. Tai ES, Fok AC, Chu R, Tan CE. A study to assess the effect of dietary supplementation with soluble fibre (Minolest) on lipid levels in normal subjects with hypercholesterolaemia. Ann Acad Med Singapore. 1999;28:209-13.
27. Turnbull W, Thomas H. The effect of a Plantago ovata seed containing preparation on appetite variables, nutrient and energy intake. Int J Obes Relat Metab Disord. 1995;19:338-42.
28. Delargy H, O'Sullivan K, Fletcher R, Blundell J. Effects of amount and type of dietary fibre (soluble and insoluble) on short-term control of appetite. Int J Food Sci Nutr. 1997;48:67-77.
29. Pal S, Radavelli-Bagatini S. Effects of psyllium on metabolic syndrome risk factors. Obes Rev. 2012;13:1034-47.
30. Galisteo M, Sanchez M, Vera R, Gonzalez M, Anguera A, Duarte J, et al. A diet supplemented with husks of Plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-alpha in obese Zucker rats. J Nutr. 2005;135.
31. Carabin IG, Lyon MR, Wood S, Pelletier X, Donazzolo Y, Burdock GA. Supplementation of the diet with the functional fiber PolyGlycoplex is well tolerated by healthy subjects in a clinical trial. Nutr J. 2009;8:9.
32. Vuksan V, Panahi S, Lyon M, Rogovik AL, Jenkins AL, Leiter LA. Viscosity of fiber preloads affects food intake in adolescents. Nutr Metab Cardiovasc Dis. 2009;19:498-503.
33. Dikeman C, Murphy M, Fahey GJ. Dietary fibers affect viscosity of solutions and simulated human gastric and small intestinal digesta. J Nutr. 2006;136:913-9.
34. Pal S, Ellis V, Dhaliwal S. Effects of whey protein isolate on body composition, lipids, insulin and glucose in overweight and obese individuals. Br J Nutr. 2010;104:716-23.
35. Toss F, Wiklund P, Nordström P, Nordström A. Body composition and mortaility risk in later life. Age Ageing. 2012;41:677-81.
36. Solah VA, Brand-Miller JC, Atkinson FS, Gahler RJ, Kacinik V, Lyon MR, et al. Dose-response effect of a novel functional fibre, PolyGlycopleX®, PGX®, on satiety. Appetite. 2014;77C:72-6.
37. Kacinik V, Lyon MR, Purnama M, Reimer RA, Gahler RJ, Green TJ, et al. Effect of PGX, a novel functional fibre supplement, on subjective ratings of appetite in overweight and obese women consuming a 3-day structured, low-calorie diet. Nutr Diab. 2011;1:e22.
38. Grover GJ, Koetzner L, Wicks J, Gahler RJ, Lyon MR, Reimer RA, et al. Effects of the soluble fiber complex PolyGlycopleX® (PGX®) on glycemic control, insulin secretion, and GLP-1 levels in Zucker diabetic rats. Life Sci. 2011;88:392-9.
39. Lyon MR, Reichert RG. The effect of a novel viscous polysaccharide along with lifestyle changes on short-term weight loss and associated risk factors in overweight and obese adults: an observational retrospective clinical program analysis. Altern Med Rev. 2010;15:68-75.
40. Reichert RG, Reimer RA, Kacinik V, Pal S, Gahler RJ, Wood S. Meal replacements and fibre supplement as a strategy for weight loss. Propriety PGX® meal replacement and PGX® fibre supplement in addition to a calorie-restricted diet to achieve weight loss in a clinical setting. Biotechnol Genet Eng Rev. 2013;29:221-9.
41. De Bock M, Derraik J, Brennan C, Biggs J, Smith G, Cameron-Smith D, et al. Psyllium supplementation in adolescents improves fat distribution & lipid profile: A randomized, participant-blinded, placebo-controlled, crossover trial. PLoS ONE. 2012;7, e41735.
42. Matulka RA, Lyon MR, Wood S, Ann Marone P, Merkel DJ, Burdock GA. The safety of PolyGlycopleX (PGX) as shown in a 90-day rodent feeding study. Nutr J. 2009;8:1.
43. Grover GJ, Koetzner L, Wicks J, Gahler RJ, Lyon MR, Reimer RA, et al. Effects of the soluble fiber complex PolyGlycopleX® on glucose homeostasis and body weight in young Zucker diabetic rats. Front Pharmacol. 2011;2:47.
44. Australian Bureau of Statistics. Australian health survey: First results 2011-2012, cat. no. 4364.0.55.001. Canberra: Australian Bureau of Statistics; 2012.